Patients suffering from multiple myeloma, a cancer of the blood cells, may soon get a new treatment option if officials from the U.S. Food and Drug Administration and the European Medicines Agency expand XGEVA to treat the illness.

The U.S. Food and Drug Administration (FDA) Blood Products Advisory Committee (BPAC) recently discussed nonacog beta pegol, a new treatment for hemophilia B, Novo Nordisk said in release.

Orexigen Therapeutics Inc. has reached an agreement to distribute weight-loss drug Mysimba in Italy.

The European Commission (EC) has authorized Pfizer’s Xeljanz oral medication to treat moderate to severe rheumatoid arthritis, which affects nearly 3 million people in Europe.

Cancer patients in the European Union (EU) are one step closer to a new treatment option for classical Hodgkin lymphoma (cHL).

AstraZeneca's Inebilizumab (formerly MEDI-551) has been granted orphan designation as a treatment for neuromyelitis optica spectrum disorder (NMOSD) by the European Medicines Agency (EMA).

Dupixent (dupilumab), an injectable drug from Sanofi and Regeneron Pharmaceuticals Inc. used to treat moderate to severe atopic dermatitis (AD), has been approved by the Food and Drug Administration (FDA).

The Food and Drug Administration (FDA) will fast-track a review of Eagle Pharmaceuticals’ Ryanodex drug to treat exertional heat stroke (EHS) following positive clinical trial data.

The Committee for Medicinal Products for Human Use, an arm of the European Commission, has recommended Bristol-Myers Squibb's Opdivo for approval, subject to final review by the full commission.

A new replacement lens for cataract sufferers blends treatment for both distance and close-up visual defects has received approval from the Food and Drug Administration.

A drug approved two years ago in the United States to treat schizophrenia is undergoing review in Europe, the final step before doctors there can prescribe it some 5 million patients suffering from the disorder.

The U.S. Patent and Trademark Office (USPTO) has issued three new patents for Eagle Pharmaceuticals Inc.'s Bendeka (bendamustine), which how has 14 patents.

Legislation designed to tie U.S. Postal Service retiree health care plans more closely with Medicare could needlessly saddle seniors with two insurance premiums, according to one health policy expert who has studied a bill introduced in the U.S. House of Representatives.

The Food and Drug Administration (FDA) has sent AstraZeneca a complete response letter (CRL) from the regulatory board in response to the development of sodium zirconium cyclosilicate, a drug designed to treat hyperkalaemia.

Pfizer Inc.'s Zavicefta, which is used the treatment of Gram-negative bacterial infections requiring hospitalization, is available in Germany and the United Kingdom.

AstraZeneca has partnered with Circassia Pharmaceuticals, a respiratory biopharmaceutical company, to develop and market two drugs that treat chronic obstructive pulmonary disease.

China Food and Drug Administration has approved Pfizer China to begin marketing Xeljanz, a drug for treating moderate to severe rheumatoid arthritis.

The Food and Drug Administration (FDA) has approved Novartis' Kisqali to be used in treating metastatic or advanced breast cancer in women. 

Lawmakers are committed to reauthorizing drug user fee agreements well before the present ones expire at the end of September, a House of Representatives committee hearing was told Wednesday.

The Food and Drug Administration has approved Merck's Keytruda for the treatment of children and adults with Hodgkin lymphoma or those have who have re-lapsed after three or more attempts at therapy.